HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.

AbstractBACKGROUND:
Mucosal delivery of therapeutic proteins using genetically modified strains of lactic acid bacteria (gmLAB) is being investigated as a new therapeutic strategy.
METHODS:
We developed a strain of gmLAB, Lactococcus lactis NZ9000 (NZ-HO), which secretes the anti-inflammatory molecule recombinant mouse heme oxygenase-1 (rmHO-1). The effects of short-term continuous oral dosing with NZ-HO were evaluated in mice with dextran sulfate sodium (DSS)-induced acute colitis as a model of inflammatory bowel diseases (IBD).
RESULTS:
We identified the secretion of rmHO-1 by NZ-HO. rmHO-1 was biologically active as determined with spectroscopy. Viable NZ-HO was directly delivered to the colon via oral administration, and rmHO-1 was secreted onto the colonic mucosa in mice. Acute colitis in mice was induced by free drinking of 3 % DSS in water and was accompanied by an increase in the disease activity index score and histopathological changes. Daily oral administration of NZ-HO significantly improved these colitis-associated symptoms. In addition, NZ-HO significantly increased production of the anti-inflammatory cytokine interleukin (IL)-10 and decreased the expression of pro-inflammatory cytokines such as IL-1α and IL-6 in the colon compared to a vector control strain.
CONCLUSIONS:
Oral administration of NZ-HO alleviates DSS-induced acute colitis in mice. Our results suggest that NZ-HO may be a useful mucosal therapeutic agent for treating IBD.
AuthorsSuguru Shigemori, Takafumi Watanabe, Kai Kudoh, Masaki Ihara, Shireen Nigar, Yoshinari Yamamoto, Yoshihito Suda, Takashi Sato, Haruki Kitazawa, Takeshi Shimosato
JournalMicrobial cell factories (Microb Cell Fact) Vol. 14 Pg. 189 (Nov 25 2015) ISSN: 1475-2859 [Electronic] England
PMID26608030 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-1alpha
  • Interleukin-6
  • Recombinant Proteins
  • Interleukin-10
  • Nisin
  • Dextran Sulfate
  • Heme Oxygenase-1
Topics
  • Acute Disease
  • Administration, Oral
  • Animals
  • Colitis (chemically induced, pathology, therapy)
  • Dextran Sulfate (toxicity)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Gene Expression Regulation, Bacterial (drug effects)
  • Heme Oxygenase-1 (genetics, metabolism)
  • Interleukin-10 (metabolism)
  • Interleukin-1alpha (metabolism)
  • Interleukin-6 (metabolism)
  • Intestinal Mucosa (metabolism, microbiology, pathology)
  • Lactococcus lactis (growth & development, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Nisin (pharmacology)
  • Recombinant Proteins (analysis, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: